Global Modified Live Vaccine Market Growth 2026-2032
The global Modified Live Vaccine market size is predicted to grow from US$ 525 million in 2025 to US$ 804 million in 2032; it is expected to grow at a CAGR of 7.2% from 2026 to 2032.
In 2025, global Modified Live Vaccine approximately 22,364 k doses, with an average global market price of around US$ 24 per dose. Gross margin is about 47%. The cost is 13 usd. The Production is about 25,000 k doses. A Modified Live Vaccine is a type of live vaccine made from a pathogen that has been weakened or genetically modified to reduce its ability to cause disease while retaining limited replication capability. After administration, it can mimic natural infection and stimulate strong and long-lasting immune responses in animals. Modified live vaccines are widely used in disease prevention for swine, cattle, sheep, poultry, and companion animals. Compared with inactivated vaccines, they usually provide stronger and faster immunity with lower doses, but they require stricter control over storage, transportation, safety, and strain stability.
Modified live vaccines will develop toward improved safety, stability, and precision. As large-scale farming and animal disease prevention requirements continue to increase, manufacturers will focus more on attenuation stability, control of reversion-to-virulence risk, duration of immunity, and cross-protection capability. Genetic attenuation, reverse genetics, vector-based vaccines, and multivalent combination vaccines will become important R&D directions, enabling broader protection against multiple pathogens or serotypes and improving immune efficacy across swine, cattle, sheep, poultry, and companion animals. At the same time, cold-chain stability, freeze-drying processes, and mass administration methods such as spray, drinking water, and intranasal delivery will continue to improve, reducing vaccination costs and increasing efficiency in large-scale applications.
LP Information, Inc. (LPI) ' newest research report, the ?Modified Live Vaccine Industry Forecast? looks at past sales and reviews total world Modified Live Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Modified Live Vaccine sales for 2026 through 2032. With Modified Live Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Modified Live Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Modified Live Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Modified Live Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Modified Live Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Modified Live Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Modified Live Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Modified Live Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Modified Live Vaccine market?
What factors are driving Modified Live Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Modified Live Vaccine market opportunities vary by end market size?
How does Modified Live Vaccine break out by Type, by Application?
In 2025, global Modified Live Vaccine approximately 22,364 k doses, with an average global market price of around US$ 24 per dose. Gross margin is about 47%. The cost is 13 usd. The Production is about 25,000 k doses. A Modified Live Vaccine is a type of live vaccine made from a pathogen that has been weakened or genetically modified to reduce its ability to cause disease while retaining limited replication capability. After administration, it can mimic natural infection and stimulate strong and long-lasting immune responses in animals. Modified live vaccines are widely used in disease prevention for swine, cattle, sheep, poultry, and companion animals. Compared with inactivated vaccines, they usually provide stronger and faster immunity with lower doses, but they require stricter control over storage, transportation, safety, and strain stability.
Modified live vaccines will develop toward improved safety, stability, and precision. As large-scale farming and animal disease prevention requirements continue to increase, manufacturers will focus more on attenuation stability, control of reversion-to-virulence risk, duration of immunity, and cross-protection capability. Genetic attenuation, reverse genetics, vector-based vaccines, and multivalent combination vaccines will become important R&D directions, enabling broader protection against multiple pathogens or serotypes and improving immune efficacy across swine, cattle, sheep, poultry, and companion animals. At the same time, cold-chain stability, freeze-drying processes, and mass administration methods such as spray, drinking water, and intranasal delivery will continue to improve, reducing vaccination costs and increasing efficiency in large-scale applications.
LP Information, Inc. (LPI) ' newest research report, the ?Modified Live Vaccine Industry Forecast? looks at past sales and reviews total world Modified Live Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Modified Live Vaccine sales for 2026 through 2032. With Modified Live Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Modified Live Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Modified Live Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Modified Live Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Modified Live Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Modified Live Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Modified Live Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Modified Live Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monovalent Live Attenuated Vaccines
- Multivalent Live Attenuated Vaccines
- Combination Live Attenuated Vaccines
- Viral Live Attenuated Vaccines
- Bacterial Live Attenuated Vaccines
- Parasitic Live Attenuated Vaccines
- Livestock
- Poultry
- Companion Animals
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Ceva Sant? Animale
- Boehringer Ingelheim Animal Health
- MSD Animal Health
- Virbac
- HIPRA
- Vetoquinol
- Phibro Animal Health
- IDT Biologika
- Vaxxinova
- KBNP Inc.
- China Pharmaceutical Group Animal Health Co., Ltd.
- Jinyu Bio-technology Co., Ltd.
What is the 10-year outlook for the global Modified Live Vaccine market?
What factors are driving Modified Live Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Modified Live Vaccine market opportunities vary by end market size?
How does Modified Live Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Modified Live Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Modified Live Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Modified Live Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Modified Live Vaccine Segment by Type
2.2.1 Monovalent Live Attenuated Vaccines
2.2.2 Multivalent Live Attenuated Vaccines
2.2.3 Combination Live Attenuated Vaccines
2.2.4 Modified Live Vaccine Sales by Type
2.2.4.1 Global Modified Live Vaccine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Modified Live Vaccine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Modified Live Vaccine Sale Price by Type (2021-2026)
2.3 Modified Live Vaccine Segment by Pathogen
2.3.1 Viral Live Attenuated Vaccines
2.3.2 Bacterial Live Attenuated Vaccines
2.3.3 Parasitic Live Attenuated Vaccines
2.3.4 Modified Live Vaccine Sales by Pathogen
2.3.4.1 Global Modified Live Vaccine Sales Market Share by Pathogen (2021-2026)
2.3.4.2 Global Modified Live Vaccine Revenue and Market Share by Pathogen (2021-2026)
2.3.4.3 Global Modified Live Vaccine Sale Price by Pathogen (2021-2026)
2.4 Modified Live Vaccine Segment by Application
2.4.1 Livestock
2.4.2 Poultry
2.4.3 Companion Animals
2.4.4 Others
2.4.5 Modified Live Vaccine Sales by Application
2.4.5.1 Global Modified Live Vaccine Sale Market Share by Application (2021-2026)
2.4.5.2 Global Modified Live Vaccine Revenue and Market Share by Application (2021-2026)
2.4.5.3 Global Modified Live Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Modified Live Vaccine Breakdown Data by Company
3.1.1 Global Modified Live Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Modified Live Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Modified Live Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Modified Live Vaccine Revenue by Company (2021-2026)
3.2.2 Global Modified Live Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Modified Live Vaccine Sale Price by Company
3.4 Key Manufacturers Modified Live Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Modified Live Vaccine Product Location Distribution
3.4.2 Players Modified Live Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MODIFIED LIVE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Modified Live Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Modified Live Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Modified Live Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Modified Live Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Modified Live Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Modified Live Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Modified Live Vaccine Sales Growth
4.4 APAC Modified Live Vaccine Sales Growth
4.5 Europe Modified Live Vaccine Sales Growth
4.6 Middle East & Africa Modified Live Vaccine Sales Growth
5 AMERICAS
5.1 Americas Modified Live Vaccine Sales by Country
5.1.1 Americas Modified Live Vaccine Sales by Country (2021-2026)
5.1.2 Americas Modified Live Vaccine Revenue by Country (2021-2026)
5.2 Americas Modified Live Vaccine Sales by Type (2021-2026)
5.3 Americas Modified Live Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Modified Live Vaccine Sales by Region
6.1.1 APAC Modified Live Vaccine Sales by Region (2021-2026)
6.1.2 APAC Modified Live Vaccine Revenue by Region (2021-2026)
6.2 APAC Modified Live Vaccine Sales by Type (2021-2026)
6.3 APAC Modified Live Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Modified Live Vaccine by Country
7.1.1 Europe Modified Live Vaccine Sales by Country (2021-2026)
7.1.2 Europe Modified Live Vaccine Revenue by Country (2021-2026)
7.2 Europe Modified Live Vaccine Sales by Type (2021-2026)
7.3 Europe Modified Live Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Modified Live Vaccine by Country
8.1.1 Middle East & Africa Modified Live Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Modified Live Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Modified Live Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Modified Live Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Modified Live Vaccine
10.3 Manufacturing Process Analysis of Modified Live Vaccine
10.4 Industry Chain Structure of Modified Live Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Modified Live Vaccine Distributors
11.3 Modified Live Vaccine Customer
12 WORLD FORECAST REVIEW FOR MODIFIED LIVE VACCINE BY GEOGRAPHIC REGION
12.1 Global Modified Live Vaccine Market Size Forecast by Region
12.1.1 Global Modified Live Vaccine Forecast by Region (2027-2032)
12.1.2 Global Modified Live Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Modified Live Vaccine Forecast by Type (2027-2032)
12.7 Global Modified Live Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Modified Live Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Ceva Sant? Animale
13.2.1 Ceva Sant? Animale Company Information
13.2.2 Ceva Sant? Animale Modified Live Vaccine Product Portfolios and Specifications
13.2.3 Ceva Sant? Animale Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ceva Sant? Animale Main Business Overview
13.2.5 Ceva Sant? Animale Latest Developments
13.3 Boehringer Ingelheim Animal Health
13.3.1 Boehringer Ingelheim Animal Health Company Information
13.3.2 Boehringer Ingelheim Animal Health Modified Live Vaccine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Animal Health Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boehringer Ingelheim Animal Health Main Business Overview
13.3.5 Boehringer Ingelheim Animal Health Latest Developments
13.4 MSD Animal Health
13.4.1 MSD Animal Health Company Information
13.4.2 MSD Animal Health Modified Live Vaccine Product Portfolios and Specifications
13.4.3 MSD Animal Health Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MSD Animal Health Main Business Overview
13.4.5 MSD Animal Health Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Modified Live Vaccine Product Portfolios and Specifications
13.5.3 Virbac Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 HIPRA
13.6.1 HIPRA Company Information
13.6.2 HIPRA Modified Live Vaccine Product Portfolios and Specifications
13.6.3 HIPRA Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 HIPRA Main Business Overview
13.6.5 HIPRA Latest Developments
13.7 Vetoquinol
13.7.1 Vetoquinol Company Information
13.7.2 Vetoquinol Modified Live Vaccine Product Portfolios and Specifications
13.7.3 Vetoquinol Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Vetoquinol Main Business Overview
13.7.5 Vetoquinol Latest Developments
13.8 Phibro Animal Health
13.8.1 Phibro Animal Health Company Information
13.8.2 Phibro Animal Health Modified Live Vaccine Product Portfolios and Specifications
13.8.3 Phibro Animal Health Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Phibro Animal Health Main Business Overview
13.8.5 Phibro Animal Health Latest Developments
13.9 IDT Biologika
13.9.1 IDT Biologika Company Information
13.9.2 IDT Biologika Modified Live Vaccine Product Portfolios and Specifications
13.9.3 IDT Biologika Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 IDT Biologika Main Business Overview
13.9.5 IDT Biologika Latest Developments
13.10 Vaxxinova
13.10.1 Vaxxinova Company Information
13.10.2 Vaxxinova Modified Live Vaccine Product Portfolios and Specifications
13.10.3 Vaxxinova Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Vaxxinova Main Business Overview
13.10.5 Vaxxinova Latest Developments
13.11 KBNP Inc.
13.11.1 KBNP Inc. Company Information
13.11.2 KBNP Inc. Modified Live Vaccine Product Portfolios and Specifications
13.11.3 KBNP Inc. Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KBNP Inc. Main Business Overview
13.11.5 KBNP Inc. Latest Developments
13.12 China Pharmaceutical Group Animal Health Co., Ltd.
13.12.1 China Pharmaceutical Group Animal Health Co., Ltd. Company Information
13.12.2 China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Product Portfolios and Specifications
13.12.3 China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 China Pharmaceutical Group Animal Health Co., Ltd. Main Business Overview
13.12.5 China Pharmaceutical Group Animal Health Co., Ltd. Latest Developments
13.13 Jinyu Bio-technology Co., Ltd.
13.13.1 Jinyu Bio-technology Co., Ltd. Company Information
13.13.2 Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Product Portfolios and Specifications
13.13.3 Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Jinyu Bio-technology Co., Ltd. Main Business Overview
13.13.5 Jinyu Bio-technology Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Modified Live Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Modified Live Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Modified Live Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Modified Live Vaccine Segment by Type
2.2.1 Monovalent Live Attenuated Vaccines
2.2.2 Multivalent Live Attenuated Vaccines
2.2.3 Combination Live Attenuated Vaccines
2.2.4 Modified Live Vaccine Sales by Type
2.2.4.1 Global Modified Live Vaccine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Modified Live Vaccine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Modified Live Vaccine Sale Price by Type (2021-2026)
2.3 Modified Live Vaccine Segment by Pathogen
2.3.1 Viral Live Attenuated Vaccines
2.3.2 Bacterial Live Attenuated Vaccines
2.3.3 Parasitic Live Attenuated Vaccines
2.3.4 Modified Live Vaccine Sales by Pathogen
2.3.4.1 Global Modified Live Vaccine Sales Market Share by Pathogen (2021-2026)
2.3.4.2 Global Modified Live Vaccine Revenue and Market Share by Pathogen (2021-2026)
2.3.4.3 Global Modified Live Vaccine Sale Price by Pathogen (2021-2026)
2.4 Modified Live Vaccine Segment by Application
2.4.1 Livestock
2.4.2 Poultry
2.4.3 Companion Animals
2.4.4 Others
2.4.5 Modified Live Vaccine Sales by Application
2.4.5.1 Global Modified Live Vaccine Sale Market Share by Application (2021-2026)
2.4.5.2 Global Modified Live Vaccine Revenue and Market Share by Application (2021-2026)
2.4.5.3 Global Modified Live Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Modified Live Vaccine Breakdown Data by Company
3.1.1 Global Modified Live Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Modified Live Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Modified Live Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Modified Live Vaccine Revenue by Company (2021-2026)
3.2.2 Global Modified Live Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Modified Live Vaccine Sale Price by Company
3.4 Key Manufacturers Modified Live Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Modified Live Vaccine Product Location Distribution
3.4.2 Players Modified Live Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MODIFIED LIVE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Modified Live Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Modified Live Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Modified Live Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Modified Live Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Modified Live Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Modified Live Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Modified Live Vaccine Sales Growth
4.4 APAC Modified Live Vaccine Sales Growth
4.5 Europe Modified Live Vaccine Sales Growth
4.6 Middle East & Africa Modified Live Vaccine Sales Growth
5 AMERICAS
5.1 Americas Modified Live Vaccine Sales by Country
5.1.1 Americas Modified Live Vaccine Sales by Country (2021-2026)
5.1.2 Americas Modified Live Vaccine Revenue by Country (2021-2026)
5.2 Americas Modified Live Vaccine Sales by Type (2021-2026)
5.3 Americas Modified Live Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Modified Live Vaccine Sales by Region
6.1.1 APAC Modified Live Vaccine Sales by Region (2021-2026)
6.1.2 APAC Modified Live Vaccine Revenue by Region (2021-2026)
6.2 APAC Modified Live Vaccine Sales by Type (2021-2026)
6.3 APAC Modified Live Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Modified Live Vaccine by Country
7.1.1 Europe Modified Live Vaccine Sales by Country (2021-2026)
7.1.2 Europe Modified Live Vaccine Revenue by Country (2021-2026)
7.2 Europe Modified Live Vaccine Sales by Type (2021-2026)
7.3 Europe Modified Live Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Modified Live Vaccine by Country
8.1.1 Middle East & Africa Modified Live Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Modified Live Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Modified Live Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Modified Live Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Modified Live Vaccine
10.3 Manufacturing Process Analysis of Modified Live Vaccine
10.4 Industry Chain Structure of Modified Live Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Modified Live Vaccine Distributors
11.3 Modified Live Vaccine Customer
12 WORLD FORECAST REVIEW FOR MODIFIED LIVE VACCINE BY GEOGRAPHIC REGION
12.1 Global Modified Live Vaccine Market Size Forecast by Region
12.1.1 Global Modified Live Vaccine Forecast by Region (2027-2032)
12.1.2 Global Modified Live Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Modified Live Vaccine Forecast by Type (2027-2032)
12.7 Global Modified Live Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Modified Live Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Ceva Sant? Animale
13.2.1 Ceva Sant? Animale Company Information
13.2.2 Ceva Sant? Animale Modified Live Vaccine Product Portfolios and Specifications
13.2.3 Ceva Sant? Animale Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ceva Sant? Animale Main Business Overview
13.2.5 Ceva Sant? Animale Latest Developments
13.3 Boehringer Ingelheim Animal Health
13.3.1 Boehringer Ingelheim Animal Health Company Information
13.3.2 Boehringer Ingelheim Animal Health Modified Live Vaccine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Animal Health Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boehringer Ingelheim Animal Health Main Business Overview
13.3.5 Boehringer Ingelheim Animal Health Latest Developments
13.4 MSD Animal Health
13.4.1 MSD Animal Health Company Information
13.4.2 MSD Animal Health Modified Live Vaccine Product Portfolios and Specifications
13.4.3 MSD Animal Health Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MSD Animal Health Main Business Overview
13.4.5 MSD Animal Health Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Modified Live Vaccine Product Portfolios and Specifications
13.5.3 Virbac Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 HIPRA
13.6.1 HIPRA Company Information
13.6.2 HIPRA Modified Live Vaccine Product Portfolios and Specifications
13.6.3 HIPRA Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 HIPRA Main Business Overview
13.6.5 HIPRA Latest Developments
13.7 Vetoquinol
13.7.1 Vetoquinol Company Information
13.7.2 Vetoquinol Modified Live Vaccine Product Portfolios and Specifications
13.7.3 Vetoquinol Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Vetoquinol Main Business Overview
13.7.5 Vetoquinol Latest Developments
13.8 Phibro Animal Health
13.8.1 Phibro Animal Health Company Information
13.8.2 Phibro Animal Health Modified Live Vaccine Product Portfolios and Specifications
13.8.3 Phibro Animal Health Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Phibro Animal Health Main Business Overview
13.8.5 Phibro Animal Health Latest Developments
13.9 IDT Biologika
13.9.1 IDT Biologika Company Information
13.9.2 IDT Biologika Modified Live Vaccine Product Portfolios and Specifications
13.9.3 IDT Biologika Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 IDT Biologika Main Business Overview
13.9.5 IDT Biologika Latest Developments
13.10 Vaxxinova
13.10.1 Vaxxinova Company Information
13.10.2 Vaxxinova Modified Live Vaccine Product Portfolios and Specifications
13.10.3 Vaxxinova Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Vaxxinova Main Business Overview
13.10.5 Vaxxinova Latest Developments
13.11 KBNP Inc.
13.11.1 KBNP Inc. Company Information
13.11.2 KBNP Inc. Modified Live Vaccine Product Portfolios and Specifications
13.11.3 KBNP Inc. Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KBNP Inc. Main Business Overview
13.11.5 KBNP Inc. Latest Developments
13.12 China Pharmaceutical Group Animal Health Co., Ltd.
13.12.1 China Pharmaceutical Group Animal Health Co., Ltd. Company Information
13.12.2 China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Product Portfolios and Specifications
13.12.3 China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 China Pharmaceutical Group Animal Health Co., Ltd. Main Business Overview
13.12.5 China Pharmaceutical Group Animal Health Co., Ltd. Latest Developments
13.13 Jinyu Bio-technology Co., Ltd.
13.13.1 Jinyu Bio-technology Co., Ltd. Company Information
13.13.2 Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Product Portfolios and Specifications
13.13.3 Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Jinyu Bio-technology Co., Ltd. Main Business Overview
13.13.5 Jinyu Bio-technology Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Modified Live Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Modified Live Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monovalent Live Attenuated Vaccines
Table 4. Major Players of Multivalent Live Attenuated Vaccines
Table 5. Major Players of Combination Live Attenuated Vaccines
Table 6. Global Modified Live Vaccine Sales by Type (2021-2026) & (K Dose)
Table 7. Global Modified Live Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Modified Live Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Modified Live Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Modified Live Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Major Players of Viral Live Attenuated Vaccines
Table 12. Major Players of Bacterial Live Attenuated Vaccines
Table 13. Major Players of Parasitic Live Attenuated Vaccines
Table 14. Global Modified Live Vaccine Sales by Pathogen (2021-2026) & (K Dose)
Table 15. Global Modified Live Vaccine Sales Market Share by Pathogen (2021-2026)
Table 16. Global Modified Live Vaccine Revenue by Pathogen (2021-2026) & ($ million)
Table 17. Global Modified Live Vaccine Revenue Market Share by Pathogen (2021-2026)
Table 18. Global Modified Live Vaccine Sale Price by Pathogen (2021-2026) & (US$/Dose)
Table 19. Global Modified Live Vaccine Sale by Application (2021-2026) & (K Dose)
Table 20. Global Modified Live Vaccine Sale Market Share by Application (2021-2026)
Table 21. Global Modified Live Vaccine Revenue by Application (2021-2026) & ($ million)
Table 22. Global Modified Live Vaccine Revenue Market Share by Application (2021-2026)
Table 23. Global Modified Live Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 24. Global Modified Live Vaccine Sales by Company (2021-2026) & (K Dose)
Table 25. Global Modified Live Vaccine Sales Market Share by Company (2021-2026)
Table 26. Global Modified Live Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Modified Live Vaccine Revenue Market Share by Company (2021-2026)
Table 28. Global Modified Live Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 29. Key Manufacturers Modified Live Vaccine Producing Area Distribution and Sales Area
Table 30. Players Modified Live Vaccine Products Offered
Table 31. Modified Live Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Modified Live Vaccine Sales by Geographic Region (2021-2026) & (K Dose)
Table 35. Global Modified Live Vaccine Sales Market Share Geographic Region (2021-2026)
Table 36. Global Modified Live Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Modified Live Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Modified Live Vaccine Sales by Country/Region (2021-2026) & (K Dose)
Table 39. Global Modified Live Vaccine Sales Market Share by Country/Region (2021-2026)
Table 40. Global Modified Live Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Modified Live Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Modified Live Vaccine Sales by Country (2021-2026) & (K Dose)
Table 43. Americas Modified Live Vaccine Sales Market Share by Country (2021-2026)
Table 44. Americas Modified Live Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Modified Live Vaccine Sales by Type (2021-2026) & (K Dose)
Table 46. Americas Modified Live Vaccine Sales by Application (2021-2026) & (K Dose)
Table 47. APAC Modified Live Vaccine Sales by Region (2021-2026) & (K Dose)
Table 48. APAC Modified Live Vaccine Sales Market Share by Region (2021-2026)
Table 49. APAC Modified Live Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Modified Live Vaccine Sales by Type (2021-2026) & (K Dose)
Table 51. APAC Modified Live Vaccine Sales by Application (2021-2026) & (K Dose)
Table 52. Europe Modified Live Vaccine Sales by Country (2021-2026) & (K Dose)
Table 53. Europe Modified Live Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Modified Live Vaccine Sales by Type (2021-2026) & (K Dose)
Table 55. Europe Modified Live Vaccine Sales by Application (2021-2026) & (K Dose)
Table 56. Middle East & Africa Modified Live Vaccine Sales by Country (2021-2026) & (K Dose)
Table 57. Middle East & Africa Modified Live Vaccine Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Modified Live Vaccine Sales by Type (2021-2026) & (K Dose)
Table 59. Middle East & Africa Modified Live Vaccine Sales by Application (2021-2026) & (K Dose)
Table 60. Key Market Drivers & Growth Opportunities of Modified Live Vaccine
Table 61. Key Market Challenges & Risks of Modified Live Vaccine
Table 62. Key Industry Trends of Modified Live Vaccine
Table 63. Modified Live Vaccine Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Modified Live Vaccine Distributors List
Table 66. Modified Live Vaccine Customer List
Table 67. Global Modified Live Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 68. Global Modified Live Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Modified Live Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 70. Americas Modified Live Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Modified Live Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 72. APAC Modified Live Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Modified Live Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 74. Europe Modified Live Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Modified Live Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 76. Middle East & Africa Modified Live Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Modified Live Vaccine Sales Forecast by Type (2027-2032) & (K Dose)
Table 78. Global Modified Live Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Modified Live Vaccine Sales Forecast by Application (2027-2032) & (K Dose)
Table 80. Global Modified Live Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. Zoetis Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 82. Zoetis Modified Live Vaccine Product Portfolios and Specifications
Table 83. Zoetis Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 84. Zoetis Main Business
Table 85. Zoetis Latest Developments
Table 86. Ceva Sant? Animale Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. Ceva Sant? Animale Modified Live Vaccine Product Portfolios and Specifications
Table 88. Ceva Sant? Animale Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 89. Ceva Sant? Animale Main Business
Table 90. Ceva Sant? Animale Latest Developments
Table 91. Boehringer Ingelheim Animal Health Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. Boehringer Ingelheim Animal Health Modified Live Vaccine Product Portfolios and Specifications
Table 93. Boehringer Ingelheim Animal Health Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 94. Boehringer Ingelheim Animal Health Main Business
Table 95. Boehringer Ingelheim Animal Health Latest Developments
Table 96. MSD Animal Health Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. MSD Animal Health Modified Live Vaccine Product Portfolios and Specifications
Table 98. MSD Animal Health Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 99. MSD Animal Health Main Business
Table 100. MSD Animal Health Latest Developments
Table 101. Virbac Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. Virbac Modified Live Vaccine Product Portfolios and Specifications
Table 103. Virbac Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 104. Virbac Main Business
Table 105. Virbac Latest Developments
Table 106. HIPRA Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. HIPRA Modified Live Vaccine Product Portfolios and Specifications
Table 108. HIPRA Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 109. HIPRA Main Business
Table 110. HIPRA Latest Developments
Table 111. Vetoquinol Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. Vetoquinol Modified Live Vaccine Product Portfolios and Specifications
Table 113. Vetoquinol Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 114. Vetoquinol Main Business
Table 115. Vetoquinol Latest Developments
Table 116. Phibro Animal Health Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 117. Phibro Animal Health Modified Live Vaccine Product Portfolios and Specifications
Table 118. Phibro Animal Health Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 119. Phibro Animal Health Main Business
Table 120. Phibro Animal Health Latest Developments
Table 121. IDT Biologika Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 122. IDT Biologika Modified Live Vaccine Product Portfolios and Specifications
Table 123. IDT Biologika Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 124. IDT Biologika Main Business
Table 125. IDT Biologika Latest Developments
Table 126. Vaxxinova Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 127. Vaxxinova Modified Live Vaccine Product Portfolios and Specifications
Table 128. Vaxxinova Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 129. Vaxxinova Main Business
Table 130. Vaxxinova Latest Developments
Table 131. KBNP Inc. Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 132. KBNP Inc. Modified Live Vaccine Product Portfolios and Specifications
Table 133. KBNP Inc. Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 134. KBNP Inc. Main Business
Table 135. KBNP Inc. Latest Developments
Table 136. China Pharmaceutical Group Animal Health Co., Ltd. Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 137. China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Product Portfolios and Specifications
Table 138. China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 139. China Pharmaceutical Group Animal Health Co., Ltd. Main Business
Table 140. China Pharmaceutical Group Animal Health Co., Ltd. Latest Developments
Table 141. Jinyu Bio-technology Co., Ltd. Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 142. Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Product Portfolios and Specifications
Table 143. Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 144. Jinyu Bio-technology Co., Ltd. Main Business
Table 145. Jinyu Bio-technology Co., Ltd. Latest Developments
Table 1. Modified Live Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Modified Live Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monovalent Live Attenuated Vaccines
Table 4. Major Players of Multivalent Live Attenuated Vaccines
Table 5. Major Players of Combination Live Attenuated Vaccines
Table 6. Global Modified Live Vaccine Sales by Type (2021-2026) & (K Dose)
Table 7. Global Modified Live Vaccine Sales Market Share by Type (2021-2026)
Table 8. Global Modified Live Vaccine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Modified Live Vaccine Revenue Market Share by Type (2021-2026)
Table 10. Global Modified Live Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 11. Major Players of Viral Live Attenuated Vaccines
Table 12. Major Players of Bacterial Live Attenuated Vaccines
Table 13. Major Players of Parasitic Live Attenuated Vaccines
Table 14. Global Modified Live Vaccine Sales by Pathogen (2021-2026) & (K Dose)
Table 15. Global Modified Live Vaccine Sales Market Share by Pathogen (2021-2026)
Table 16. Global Modified Live Vaccine Revenue by Pathogen (2021-2026) & ($ million)
Table 17. Global Modified Live Vaccine Revenue Market Share by Pathogen (2021-2026)
Table 18. Global Modified Live Vaccine Sale Price by Pathogen (2021-2026) & (US$/Dose)
Table 19. Global Modified Live Vaccine Sale by Application (2021-2026) & (K Dose)
Table 20. Global Modified Live Vaccine Sale Market Share by Application (2021-2026)
Table 21. Global Modified Live Vaccine Revenue by Application (2021-2026) & ($ million)
Table 22. Global Modified Live Vaccine Revenue Market Share by Application (2021-2026)
Table 23. Global Modified Live Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 24. Global Modified Live Vaccine Sales by Company (2021-2026) & (K Dose)
Table 25. Global Modified Live Vaccine Sales Market Share by Company (2021-2026)
Table 26. Global Modified Live Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 27. Global Modified Live Vaccine Revenue Market Share by Company (2021-2026)
Table 28. Global Modified Live Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 29. Key Manufacturers Modified Live Vaccine Producing Area Distribution and Sales Area
Table 30. Players Modified Live Vaccine Products Offered
Table 31. Modified Live Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 32. New Products and Potential Entrants
Table 33. Market M&A Activity & Strategy
Table 34. Global Modified Live Vaccine Sales by Geographic Region (2021-2026) & (K Dose)
Table 35. Global Modified Live Vaccine Sales Market Share Geographic Region (2021-2026)
Table 36. Global Modified Live Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 37. Global Modified Live Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 38. Global Modified Live Vaccine Sales by Country/Region (2021-2026) & (K Dose)
Table 39. Global Modified Live Vaccine Sales Market Share by Country/Region (2021-2026)
Table 40. Global Modified Live Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 41. Global Modified Live Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 42. Americas Modified Live Vaccine Sales by Country (2021-2026) & (K Dose)
Table 43. Americas Modified Live Vaccine Sales Market Share by Country (2021-2026)
Table 44. Americas Modified Live Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Americas Modified Live Vaccine Sales by Type (2021-2026) & (K Dose)
Table 46. Americas Modified Live Vaccine Sales by Application (2021-2026) & (K Dose)
Table 47. APAC Modified Live Vaccine Sales by Region (2021-2026) & (K Dose)
Table 48. APAC Modified Live Vaccine Sales Market Share by Region (2021-2026)
Table 49. APAC Modified Live Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 50. APAC Modified Live Vaccine Sales by Type (2021-2026) & (K Dose)
Table 51. APAC Modified Live Vaccine Sales by Application (2021-2026) & (K Dose)
Table 52. Europe Modified Live Vaccine Sales by Country (2021-2026) & (K Dose)
Table 53. Europe Modified Live Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 54. Europe Modified Live Vaccine Sales by Type (2021-2026) & (K Dose)
Table 55. Europe Modified Live Vaccine Sales by Application (2021-2026) & (K Dose)
Table 56. Middle East & Africa Modified Live Vaccine Sales by Country (2021-2026) & (K Dose)
Table 57. Middle East & Africa Modified Live Vaccine Revenue Market Share by Country (2021-2026)
Table 58. Middle East & Africa Modified Live Vaccine Sales by Type (2021-2026) & (K Dose)
Table 59. Middle East & Africa Modified Live Vaccine Sales by Application (2021-2026) & (K Dose)
Table 60. Key Market Drivers & Growth Opportunities of Modified Live Vaccine
Table 61. Key Market Challenges & Risks of Modified Live Vaccine
Table 62. Key Industry Trends of Modified Live Vaccine
Table 63. Modified Live Vaccine Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Modified Live Vaccine Distributors List
Table 66. Modified Live Vaccine Customer List
Table 67. Global Modified Live Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 68. Global Modified Live Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Americas Modified Live Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 70. Americas Modified Live Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. APAC Modified Live Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 72. APAC Modified Live Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Europe Modified Live Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 74. Europe Modified Live Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. Middle East & Africa Modified Live Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 76. Middle East & Africa Modified Live Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. Global Modified Live Vaccine Sales Forecast by Type (2027-2032) & (K Dose)
Table 78. Global Modified Live Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 79. Global Modified Live Vaccine Sales Forecast by Application (2027-2032) & (K Dose)
Table 80. Global Modified Live Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 81. Zoetis Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 82. Zoetis Modified Live Vaccine Product Portfolios and Specifications
Table 83. Zoetis Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 84. Zoetis Main Business
Table 85. Zoetis Latest Developments
Table 86. Ceva Sant? Animale Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. Ceva Sant? Animale Modified Live Vaccine Product Portfolios and Specifications
Table 88. Ceva Sant? Animale Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 89. Ceva Sant? Animale Main Business
Table 90. Ceva Sant? Animale Latest Developments
Table 91. Boehringer Ingelheim Animal Health Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. Boehringer Ingelheim Animal Health Modified Live Vaccine Product Portfolios and Specifications
Table 93. Boehringer Ingelheim Animal Health Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 94. Boehringer Ingelheim Animal Health Main Business
Table 95. Boehringer Ingelheim Animal Health Latest Developments
Table 96. MSD Animal Health Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. MSD Animal Health Modified Live Vaccine Product Portfolios and Specifications
Table 98. MSD Animal Health Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 99. MSD Animal Health Main Business
Table 100. MSD Animal Health Latest Developments
Table 101. Virbac Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. Virbac Modified Live Vaccine Product Portfolios and Specifications
Table 103. Virbac Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 104. Virbac Main Business
Table 105. Virbac Latest Developments
Table 106. HIPRA Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. HIPRA Modified Live Vaccine Product Portfolios and Specifications
Table 108. HIPRA Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 109. HIPRA Main Business
Table 110. HIPRA Latest Developments
Table 111. Vetoquinol Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. Vetoquinol Modified Live Vaccine Product Portfolios and Specifications
Table 113. Vetoquinol Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 114. Vetoquinol Main Business
Table 115. Vetoquinol Latest Developments
Table 116. Phibro Animal Health Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 117. Phibro Animal Health Modified Live Vaccine Product Portfolios and Specifications
Table 118. Phibro Animal Health Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 119. Phibro Animal Health Main Business
Table 120. Phibro Animal Health Latest Developments
Table 121. IDT Biologika Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 122. IDT Biologika Modified Live Vaccine Product Portfolios and Specifications
Table 123. IDT Biologika Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 124. IDT Biologika Main Business
Table 125. IDT Biologika Latest Developments
Table 126. Vaxxinova Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 127. Vaxxinova Modified Live Vaccine Product Portfolios and Specifications
Table 128. Vaxxinova Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 129. Vaxxinova Main Business
Table 130. Vaxxinova Latest Developments
Table 131. KBNP Inc. Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 132. KBNP Inc. Modified Live Vaccine Product Portfolios and Specifications
Table 133. KBNP Inc. Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 134. KBNP Inc. Main Business
Table 135. KBNP Inc. Latest Developments
Table 136. China Pharmaceutical Group Animal Health Co., Ltd. Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 137. China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Product Portfolios and Specifications
Table 138. China Pharmaceutical Group Animal Health Co., Ltd. Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 139. China Pharmaceutical Group Animal Health Co., Ltd. Main Business
Table 140. China Pharmaceutical Group Animal Health Co., Ltd. Latest Developments
Table 141. Jinyu Bio-technology Co., Ltd. Basic Information, Modified Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 142. Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Product Portfolios and Specifications
Table 143. Jinyu Bio-technology Co., Ltd. Modified Live Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 144. Jinyu Bio-technology Co., Ltd. Main Business
Table 145. Jinyu Bio-technology Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Modified Live Vaccine
Figure 2. Modified Live Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Modified Live Vaccine Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Modified Live Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Modified Live Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Modified Live Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Modified Live Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monovalent Live Attenuated Vaccines
Figure 12. Product Picture of Multivalent Live Attenuated Vaccines
Figure 13. Product Picture of Combination Live Attenuated Vaccines
Figure 14. Global Modified Live Vaccine Sales Market Share by Type in 2026
Figure 15. Global Modified Live Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Viral Live Attenuated Vaccines
Figure 17. Product Picture of Bacterial Live Attenuated Vaccines
Figure 18. Product Picture of Parasitic Live Attenuated Vaccines
Figure 19. Global Modified Live Vaccine Sales Market Share by Pathogen in 2026
Figure 20. Global Modified Live Vaccine Revenue Market Share by Pathogen (2021-2026)
Figure 21. Modified Live Vaccine Consumed in Livestock
Figure 22. Global Modified Live Vaccine Market: Livestock (2021-2026) & (K Dose)
Figure 23. Modified Live Vaccine Consumed in Poultry
Figure 24. Global Modified Live Vaccine Market: Poultry (2021-2026) & (K Dose)
Figure 25. Modified Live Vaccine Consumed in Companion Animals
Figure 26. Global Modified Live Vaccine Market: Companion Animals (2021-2026) & (K Dose)
Figure 27. Modified Live Vaccine Consumed in Others
Figure 28. Global Modified Live Vaccine Market: Others (2021-2026) & (K Dose)
Figure 29. Global Modified Live Vaccine Sale Market Share by Application (2025)
Figure 30. Global Modified Live Vaccine Revenue Market Share by Application in 2025
Figure 31. Modified Live Vaccine Sales by Company in 2025 (K Dose)
Figure 32. Global Modified Live Vaccine Sales Market Share by Company in 2025
Figure 33. Modified Live Vaccine Revenue by Company in 2025 ($ millions)
Figure 34. Global Modified Live Vaccine Revenue Market Share by Company in 2025
Figure 35. Global Modified Live Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Modified Live Vaccine Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Modified Live Vaccine Sales 2021-2026 (K Dose)
Figure 38. Americas Modified Live Vaccine Revenue 2021-2026 ($ millions)
Figure 39. APAC Modified Live Vaccine Sales 2021-2026 (K Dose)
Figure 40. APAC Modified Live Vaccine Revenue 2021-2026 ($ millions)
Figure 41. Europe Modified Live Vaccine Sales 2021-2026 (K Dose)
Figure 42. Europe Modified Live Vaccine Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Modified Live Vaccine Sales 2021-2026 (K Dose)
Figure 44. Middle East & Africa Modified Live Vaccine Revenue 2021-2026 ($ millions)
Figure 45. Americas Modified Live Vaccine Sales Market Share by Country in 2025
Figure 46. Americas Modified Live Vaccine Revenue Market Share by Country (2021-2026)
Figure 47. Americas Modified Live Vaccine Sales Market Share by Type (2021-2026)
Figure 48. Americas Modified Live Vaccine Sales Market Share by Application (2021-2026)
Figure 49. United States Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Modified Live Vaccine Sales Market Share by Region in 2025
Figure 54. APAC Modified Live Vaccine Revenue Market Share by Region (2021-2026)
Figure 55. APAC Modified Live Vaccine Sales Market Share by Type (2021-2026)
Figure 56. APAC Modified Live Vaccine Sales Market Share by Application (2021-2026)
Figure 57. China Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. India Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Modified Live Vaccine Sales Market Share by Country in 2025
Figure 65. Europe Modified Live Vaccine Revenue Market Share by Country (2021-2026)
Figure 66. Europe Modified Live Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Europe Modified Live Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Germany Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. France Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Modified Live Vaccine Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Modified Live Vaccine Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Modified Live Vaccine Sales Market Share by Application (2021-2026)
Figure 76. Egypt Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Modified Live Vaccine in 2026
Figure 82. Manufacturing Process Analysis of Modified Live Vaccine
Figure 83. Industry Chain Structure of Modified Live Vaccine
Figure 84. Channels of Distribution
Figure 85. Global Modified Live Vaccine Sales Market Forecast by Region (2027-2032)
Figure 86. Global Modified Live Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Modified Live Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Modified Live Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Modified Live Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Modified Live Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Modified Live Vaccine
Figure 2. Modified Live Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Modified Live Vaccine Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Modified Live Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Modified Live Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Modified Live Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Modified Live Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monovalent Live Attenuated Vaccines
Figure 12. Product Picture of Multivalent Live Attenuated Vaccines
Figure 13. Product Picture of Combination Live Attenuated Vaccines
Figure 14. Global Modified Live Vaccine Sales Market Share by Type in 2026
Figure 15. Global Modified Live Vaccine Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Viral Live Attenuated Vaccines
Figure 17. Product Picture of Bacterial Live Attenuated Vaccines
Figure 18. Product Picture of Parasitic Live Attenuated Vaccines
Figure 19. Global Modified Live Vaccine Sales Market Share by Pathogen in 2026
Figure 20. Global Modified Live Vaccine Revenue Market Share by Pathogen (2021-2026)
Figure 21. Modified Live Vaccine Consumed in Livestock
Figure 22. Global Modified Live Vaccine Market: Livestock (2021-2026) & (K Dose)
Figure 23. Modified Live Vaccine Consumed in Poultry
Figure 24. Global Modified Live Vaccine Market: Poultry (2021-2026) & (K Dose)
Figure 25. Modified Live Vaccine Consumed in Companion Animals
Figure 26. Global Modified Live Vaccine Market: Companion Animals (2021-2026) & (K Dose)
Figure 27. Modified Live Vaccine Consumed in Others
Figure 28. Global Modified Live Vaccine Market: Others (2021-2026) & (K Dose)
Figure 29. Global Modified Live Vaccine Sale Market Share by Application (2025)
Figure 30. Global Modified Live Vaccine Revenue Market Share by Application in 2025
Figure 31. Modified Live Vaccine Sales by Company in 2025 (K Dose)
Figure 32. Global Modified Live Vaccine Sales Market Share by Company in 2025
Figure 33. Modified Live Vaccine Revenue by Company in 2025 ($ millions)
Figure 34. Global Modified Live Vaccine Revenue Market Share by Company in 2025
Figure 35. Global Modified Live Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Modified Live Vaccine Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Modified Live Vaccine Sales 2021-2026 (K Dose)
Figure 38. Americas Modified Live Vaccine Revenue 2021-2026 ($ millions)
Figure 39. APAC Modified Live Vaccine Sales 2021-2026 (K Dose)
Figure 40. APAC Modified Live Vaccine Revenue 2021-2026 ($ millions)
Figure 41. Europe Modified Live Vaccine Sales 2021-2026 (K Dose)
Figure 42. Europe Modified Live Vaccine Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Modified Live Vaccine Sales 2021-2026 (K Dose)
Figure 44. Middle East & Africa Modified Live Vaccine Revenue 2021-2026 ($ millions)
Figure 45. Americas Modified Live Vaccine Sales Market Share by Country in 2025
Figure 46. Americas Modified Live Vaccine Revenue Market Share by Country (2021-2026)
Figure 47. Americas Modified Live Vaccine Sales Market Share by Type (2021-2026)
Figure 48. Americas Modified Live Vaccine Sales Market Share by Application (2021-2026)
Figure 49. United States Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Modified Live Vaccine Sales Market Share by Region in 2025
Figure 54. APAC Modified Live Vaccine Revenue Market Share by Region (2021-2026)
Figure 55. APAC Modified Live Vaccine Sales Market Share by Type (2021-2026)
Figure 56. APAC Modified Live Vaccine Sales Market Share by Application (2021-2026)
Figure 57. China Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. India Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Modified Live Vaccine Sales Market Share by Country in 2025
Figure 65. Europe Modified Live Vaccine Revenue Market Share by Country (2021-2026)
Figure 66. Europe Modified Live Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Europe Modified Live Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Germany Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. France Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Modified Live Vaccine Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Modified Live Vaccine Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Modified Live Vaccine Sales Market Share by Application (2021-2026)
Figure 76. Egypt Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Modified Live Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Modified Live Vaccine in 2026
Figure 82. Manufacturing Process Analysis of Modified Live Vaccine
Figure 83. Industry Chain Structure of Modified Live Vaccine
Figure 84. Channels of Distribution
Figure 85. Global Modified Live Vaccine Sales Market Forecast by Region (2027-2032)
Figure 86. Global Modified Live Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Modified Live Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Modified Live Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Modified Live Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Modified Live Vaccine Revenue Market Share Forecast by Application (2027-2032)
